US2019017073A1PendingUtilityA1
Compositions and methods for delivering nucleic acid to a cell
Est. expiryFeb 15, 2031(~4.6 yrs left)· nominal 20-yr term from priority
C12N 15/88A61K 47/6913C12N 2320/32A61K 9/1271C12N 2310/531C12N 15/113A61K 48/0033C12N 2310/14
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided are novel compositions useful for delivering nucleic acids to cells. Also provided are methods for making and using such compositions.
Claims
exact text as granted — not AI-modified1 . A method for preparing a liposome comprising a nucleic acid
and a lipid component, the method comprising:
combining a lipid component and a nucleic acid component in a mixture comprising:
water;
a water-miscible organic solvent;
a polyamine that is spermine, spermidine, or putrescine; and
a total lipid;
wherein the lipid component comprises a combination of a neutral lipid and a cationic lipid that is less than 0.5% of the total lipid under conditions such that a liposome comprising the nucleic acid and the liposome component is formed.
2 - 3 . (canceled)
4 . The method of claim 1 , wherein the polyamine is spermine.
5 . The method of claim 1 , wherein the nucleic acid is DNA.
6 . The method of claim 1 , wherein the nucleic acid is RNA.
7 . The method of claim 6 , wherein the RNA is siRNA.
8 . The method of claim 6 , wherein the RNA is shRNA.
9 . The method of claim 1 , wherein the lipid component comprises a non-cationic lipid.
10 . The method of claim 1 , wherein the neutral lipid comprises a non-cationic lipid.
11 . The method of claim 1 , wherein the neutral lipid comprises DOPC, DOPE, cholesterol, or PEG-DSG.
12 . The method of claim 9 , wherein the liposome further comprises a cationic lipid.
13 . The method of claim 12 , wherein the cationic lipid comprises DOTAP or DOSPA.
14 . The method of claim 1 , wherein the water-miscible organic solvent comprises methanol, ethanol, 1-propanol, or 2-propanol.
15 . The method of claim 1 , wherein the lipid component contains no cationic lipid.
16 . The method of claim 1 , wherein the ratio of water to water-miscible organic solvent is between about 2:1 and 1:2.
17 . The method of claim 1 , wherein the ratio of water to water-miscible organic solvent is about 1:1
18 . (canceled)
19 . The method of claim 17 , wherein the ratio of polyamine nitrogen to nucleic acid phosphate groups (N/P) is between about 0.8 and about 1.5.
20 . (canceled)
21 . The method of claim 19 , wherein the step of combining is performed at a temperature between about 40° C. and about 50° C.
22 . The method of claim 21 , wherein the step of combining is performed at a pH not less than about 6.5.
23 - 24 . (canceled)
25 . The method of claim 14 , wherein the lipid component comprises a neutral phospholipid and no cationic lipid, and wherein the nucleic acid and the lipid component are present at a ratio of 5-20 nmol lipid per microgram of the nucleic acid, and wherein the liposome is from 30 to 500 nanometers in diameter.
26 - 51 . (canceled)Join the waitlist — get patent alerts
Track US2019017073A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.